Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Article · Originalarbeit

A Double-Blind, Randomized, Homeopathic Pathogenetic Trial with Healthy Persons: Comparing Two High Potencies

Möllinger H.a · Schneider R.b · Löffel M.c · Walach H.b

Author affiliations

aHealth Center Sokrates, Güttingen, Switzerland bInstitute for Environmental Medicine and Hospital Epidemiology, University Hospital Freiburg, Germany cHeart Center Lahr, Germany

Related Articles for ""

Forsch Komplementärmed Klass Naturheilkd 2004;11:274-280

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Article · Originalarbeit

Published online: November 12, 2004
Issue release date: November 2004

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 0

ISSN: 2504-2092 (Print)
eISSN: 2504-2106 (Online)

For additional information: http://www.karger.com/CMR

Abstract

Background and Objective: According to homeopathic theory, symptoms provoked by the homeopathic remedy in a pathogenetic trial (PT) make up the remedy picture serving as the basis for the homeopathic treatment. Little is known whether the symptoms produced by the remedy differ from symptoms produced by placebo. This is because both homeopathic remedy and placebo also produce so-called unspecific effects due to psychological reasons. We therefore explore the distinctiveness of homeopathic symptoms and placebo symptoms. Design: A three-armed, randomized PT pilot study. Setting: A blinded materia medica expert identifies symptoms with regard to their number and specificity. Participants: 21 healthy homeopathic practitioners note symptoms produced after remedy intake. Interventions: Patients are randomly assigned to receive either (1) Calendula officinalis, (2) Ferrum muriaticum, or (3) placebo. After a seven-day baseline symptoms recording period, proving substances are taken until symptoms occur. In daily supervision phone calls, symptoms are verified by the supervisor. Main Outcome Measure: Total number of symptoms produced and number of specific symptoms produced. Outlook: The results showed that both remedies ‚produced‚ significantly more symptoms than placebo. With regard to the specificity, the Calendula officinalis group displayed more remedy-specific symptoms than placebo. However, in the Ferrum muriaticum group more Calendula symptoms than placebo were also recorded.


Article / Publication Details

First-Page Preview
Abstract of Original Article · Originalarbeit

Published online: November 12, 2004
Issue release date: November 2004

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 0

ISSN: 2504-2092 (Print)
eISSN: 2504-2106 (Online)

For additional information: http://www.karger.com/CMR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.